Signal Prescription digital therapeutics enter national health systems

Summary

Reliance on AI keeps growing, connectivity is reaching places that used to be offline, and 94.7% of all internet users are on social media. Rather than complete disconnection or unmanaged escapism, prescription-based digital therapeutics may play a larger role in digital wellness in 2026 and beyond. These tools can track stress patterns, adjust interventions and set personalised boundaries between being connected and resting. The US Food and Drug Administration has authorised 13 prescription digital therapeutics and approved 192 digital therapeutic applications. Austria, Belgium, France and Germany are integrating such therapeutics into their national healthcare systems.